Variables | CSF protein | CSF cell count | CSF lymphocyte % | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Low (≤ 45) | High (> 45) | N (%) | p | No (≤ 5) | Yes (> 5) | N (%) | p | ≤ 50% | > 50% | N (%) | p | |
Age | ||||||||||||
 50+ | 0 (0) | 1 (100) | 1 (14.3) | 0.4 | 0 (0) | 1 (100) | 1 (20) | 1 | No CSF | No CSF |  | NA |
 < 50 | 4 (67) | 2 (33) | 6 (85.7) |  | 2 (50) | 2 (50) | 4 (80) |  | 3(75) | 1(25) | 4(100) |  |
Gender | ||||||||||||
 Female | 1 (50) | 1 (50) | 2 (28.6) | 1 | 1 (100) | 0 (0) | 1 (20) | 0.4 | 1 (100) | 0 (0) | 1 (25) | 1 |
 Male | 3 (60) | 2 (40) | 5 (71.4) |  | 1 (25) | 3 (75) | 4 (80) |  | 2 (67) | 1 (33) | 3 (75) |  |
COVID-19 severitya | ||||||||||||
 Non-severe | 3 (50) | 3 (50) | 6 (85.7) | 1 | 1 (25) | 3 (75) | 4 (80) | 0.4 | 2 (67) | 1 (33) | 3 (75) | 1 |
 Severe | 1 (100) | 0 (0) | 1 (14.3) |  | 1 (100) | 0 (0) | 1 (20) |  | 1 (100) | 0 (0) | 1 (25) |  |
Fatality | ||||||||||||
 Non-fatal | 4 (57.1) | 3 (42.9) | 7 (100) | NA | 2 (40) | 3 (60) | 5 (100) | NA | 3 (75) | 1 (25) | 4 (100) | NA |
 Fatal | 0 | 0 | 0 |  | 0 | 0 | 0 |  | 0 | 0 | 0 |  |